Glassman Wealth Services - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 119 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Glassman Wealth Services ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,231
-20.0%
920.0%0.00%0.0%
Q2 2023$5,287
+53.2%
920.0%0.00%0.0%
Q1 2023$3,450
+33.8%
920.0%0.00%
Q4 2022$2,578
-14.1%
92
-5.2%
0.00%
-100.0%
Q3 2022$3,000
-25.0%
97
-9.3%
0.00%0.0%
Q2 2022$4,0000.0%107
+9.2%
0.00%0.0%
Q1 2022$4,000
+100.0%
98
+10.1%
0.00%
Q4 2021$2,000
+100.0%
89
+56.1%
0.00%
Q3 2021$1,00057
+375.0%
0.00%
Q2 2021$012
-14.3%
0.00%
Q4 2019$0
-100.0%
14
-72.0%
0.00%
Q3 2019$1,00050
+316.7%
0.00%
Q2 2019$0120.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders